
MRTNZ Investment Office · S&P 500 · The 360 Vantage
DOW · NYSE
Dow Inc. Common Stock
Industrials · Major Chemicals
Reference price$28.85As of Jul 28, 2026
Street view
Analyst targets
Published sell-side aggregation—not an MRTNZ forecast.
Forward calendar
Current earnings expectations
Consensus may change until the company reports.
Dec 2026$2.62Street EPS consensus
Dec 2027$1.82Street EPS consensus
Dec 2028$2.33Street EPS consensus
Reported results
Annual financial snapshot
Fiscal period ended Dec 31, 2025.
MetricCurrentPrior
Revenue-7.0% YoY$39.97B$42.96B
Operating income($1.7B)$1.8B
Net income($2.86B)$1.11B
Operating cash flow$1.03B$2.91B
Capital expenditures($2.48B)($2.94B)
Current context
Related news
Company-linked articles surfaced by Nasdaq.
Evidence
Sources & method
Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →
Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.